These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Etretinate. Appropriate use in severe psoriasis. Lowe NJ; Roenigk H; Voorhees JJ Arch Dermatol; 1988 Apr; 124(4):527-8. PubMed ID: 3281595 [No Abstract] [Full Text] [Related]
24. Hepatotoxic reactions in a patient treated with etretinate. Weiss VC; West DP; Ackerman R; Robinson LA Arch Dermatol; 1984 Jan; 120(1):104-6. PubMed ID: 6691707 [TBL] [Abstract][Full Text] [Related]
25. Serial liver biopsies in psoriatic patients receiving long-term etretinate. Roenigk HH; Gibstine C; Glazer S; Sparberg M; Yokoo H Br J Dermatol; 1985 Jan; 112(1):77-81. PubMed ID: 3970836 [TBL] [Abstract][Full Text] [Related]
26. [Combination of etretinate and dithrocream for severe psoriasis]. Vardy D; Werner E Harefuah; 1988 Apr; 114(7):342-4. PubMed ID: 3371786 [No Abstract] [Full Text] [Related]
27. Excess granulation tissue during etretinate therapy. Hodak E; David M; Feuerman EJ J Am Acad Dermatol; 1984 Dec; 11(6):1166-7. PubMed ID: 6512060 [No Abstract] [Full Text] [Related]
28. [Treatment of psoriasis with etretinate (Tigason)]. Schuppli R Ther Umsch; 1986 Sep; 43(9):684-8. PubMed ID: 3535152 [No Abstract] [Full Text] [Related]
29. [Rupture of atrophic striae during pustular psoriasis treated with etretinate (Tigason)]. Bordier C; Flechet ML; Thomine E; Lauret P Ann Dermatol Venereol; 1984; 111(10):929-31. PubMed ID: 6098213 [No Abstract] [Full Text] [Related]
30. [Unusual side effects in patients with psoriatic erythroderma treated with etretinate (RO 10-9359)]. Castel T; Castro J; Lecha M; Mascaró JM Med Cutan Ibero Lat Am; 1986; 14(2):83-6. PubMed ID: 2943953 [TBL] [Abstract][Full Text] [Related]
35. Etretinate-induced skeletal muscle damage. Hodak E; David M; Gadoth N; Sandbank M Br J Dermatol; 1987 May; 116(5):623-6. PubMed ID: 2954577 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of etretinate and acitretin with special reference to treatment of psoriasis. Larsen FG Acta Derm Venereol Suppl (Stockh); 1994; 190():1-33. PubMed ID: 7900497 [No Abstract] [Full Text] [Related]
37. Comparison of etretinate (Tigason) and parenteral gold in the treatment of psoriatic arthropathy. Seppälä J; Laulainen M; Reunala T Clin Rheumatol; 1988 Dec; 7(4):498-503. PubMed ID: 3149925 [TBL] [Abstract][Full Text] [Related]
38. [Treatment of psoriatic rheumatism with a retinoid derivative: etretinate. Open preliminary trial on 12 patients reviewed after 6 months]. Rampon S; Fraysse MP; Ristori JM; Sauvezie B; Bussière JL; Souteyrand P Rev Rhum Mal Osteoartic; 1985 Feb; 52(2):127-31. PubMed ID: 3872473 [No Abstract] [Full Text] [Related]
39. [A case of psoriasis vulgaris whose lipoprotein lipase activity decreased during treatment with etretinate]. Seishima M; Mori S; Seishima M; Noma A Nihon Hifuka Gakkai Zasshi; 1989 May; 99(6):731-4. PubMed ID: 2585775 [TBL] [Abstract][Full Text] [Related]
40. Treatment of psoriatic arthropathy with etretinate: a two-year follow-up. Chieregato GC; Leoni A Acta Derm Venereol; 1986; 66(4):321-4. PubMed ID: 2430403 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]